| 2025-11-05 |
详情>>
股本变动：
变动后总股本8743.67万股
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.87美元,归母净利润-5527.4万美元,同比去年增长-2431.25%
|
| 2025-10-24 |
复牌提示：
2025-10-24 09:39:38 停牌，复牌日期 2025-10-24 09:44:38
|
| 2025-10-23 |
详情>>
内部人交易：
Craig Adam R股份增加86206.00股
|
| 2025-08-08 |
详情>>
业绩披露：
2025年中报每股收益-3.59美元,归母净利润-2545.9万美元,同比去年增长-165.17%
|
| 2025-05-01 |
详情>>
业绩披露：
2025年一季报每股收益0.04美元,归母净利润28.20万美元,同比去年增长100.54%
|
| 2025-05-01 |
财报披露：
美东时间 2025-05-01 盘前发布财报
|
| 2025-04-27 |
详情>>
拆分方案：
每30.0000合并分成1.0000股
|
| 2025-04-25 |
股东大会：
将于2025-06-09召开股东大会
会议内容 ▼▲
- 1.To elect the one nominee named in the accompanying proxy statement (the “Proxy Statement”), R. Keith Woods, to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders and until his successor is duly elected and qualified until his earlier death, resignation or removal.
2.To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025.
3.To hold a non-binding advisory “say-on-pay” vote on our named executive officer compensation.
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2025-03-26 |
详情>>
业绩披露：
2024年年报每股收益-0.19美元,归母净利润-3745万美元,同比去年增长62.98%
|
| 2025-03-26 |
详情>>
业绩披露：
2022年年报每股收益-1.52美元,归母净利润-9132.1万美元,同比去年增长11.03%
|
| 2025-03-24 |
股东大会：
将于2025-04-17召开股东大会
会议内容 ▼▲
- 1.The approval of an amendment to our Restated Certificate of Incorporation, as amended (“Certificate of Incorporation”) to combine outstanding shares of our common stock, par value $0.001 per share (“Common Stock”), into a lesser number of outstanding shares (the “Reverse Stock Split”), by a ratio of not less than one-for-fifteen and not more than one-for-thirty, with the exact ratio to be set within this range by our board of directors (the “Board”) in its sole discretion (the “Reverse Stock Split Proposal” or “Proposal No. 1”).
2.The approval of an adjournment of the Special Meeting, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes in favor of Proposal No. 1 (the “Adjournment Proposal” or “Proposal No. 2”).
|
| 2024-11-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.01美元,归母净利润237.10万美元,同比去年增长102.89%
|
| 2024-08-08 |
详情>>
业绩披露：
2023年中报每股收益-0.51美元,归母净利润-7973.2万美元,同比去年增长-75.48%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益0.20美元,归母净利润3906.70万美元,同比去年增长149.00%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.26美元,归母净利润-5176.6万美元,同比去年增长-115.51%
|
| 2024-04-29 |
股东大会：
将于2024-06-10召开股东大会
会议内容 ▼▲
- 1.To elect the three nominees named in the accompanying proxy statement (the “Proxy Statement”), David McGirr, M.B.A; Paula Ragan, Ph.D.; and Michael S. Wyzga, to the Board of Directors to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified until their earlier death, resignation or removal.
2.To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.
3.To hold a non-binding advisory “say-on-pay” vote on our named executive officer compensation.
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2024-03-21 |
详情>>
业绩披露：
2023年年报每股收益-0.57美元,归母净利润-1.01亿美元,同比去年增长-10.78%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.48美元,归母净利润-8203.7万美元,同比去年增长-21.88%
|
| 2023-04-25 |
股东大会：
将于2023-06-13召开股东大会
会议内容 ▼▲
- 1.To elect the three (3) nominees named in the accompanying proxy statement (the “Proxy Statement”), Gary J. Bridger, Ph.D., Francoise de Craecker and Murray W. Stewart, M.D., to the Board of Directors to hold office until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
2.To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023.
3.To hold an advisory “say-on-pay” vote on our executive compensation.
4.To hold an advisory vote on the frequency of future advisory votes on executive compensation (“say-on-frequency”).
5.To approve the Company’s Amended and Restated 2017 Employee Stock Purchase Plan.
6.To conduct any other business properly brought before the Annual Meeting.
|
| 2022-08-11 |
股东大会：
将于2022-09-01召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to the Company’s Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 125,000,000 to 500,000,000. We refer to this proposal as the “Increase in Number of Authorized Shares of Common Stock Proposal” or “Proposal 1.”
2.To approve one or more adjournments of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the foregoing proposal. We refer to this proposal as the “Adjournment Proposal” or “Proposal 2.”
|
| 2022-04-25 |
股东大会：
将于2022-06-06召开股东大会
会议内容 ▼▲
- 1.To elect the two (2) nominees named in the accompanying proxy statement (the “Proxy Statement”), William E. Aliski, MPA and Alison Lawton, to the Board of Directors to hold office until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
2.To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022.
3.To conduct any other business properly brought before the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-20 |
股东大会：
将于2021-06-02召开股东大会
会议内容 ▼▲
- 1.To elect the three (3) nominees named in the accompanying proxy statement (the “Proxy Statement”), David McGirr, M.B.A., Paula Ragan, Ph.D. and Michael S. Wyzga, to the Board of Directors to hold office until the 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
2.To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2021.
3.To conduct any other business properly brought before the Annual Meeting.
|
| 2020-04-28 |
股东大会：
将于2020-06-10召开股东大会
会议内容 ▼▲
- 1.To elect the two (2) nominees named in the accompanying proxy statement (the “Proxy Statement”), Gary J. Bridger, Ph.D. and Murray Stewart, M.D., to the Board of Directors to hold office until the 2023 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
2.To approve the Company’s Amended and Restated 2017 Equity Incentive Plan.
3.To approve an amendment to the Company’s Certificate of Incorporation to increase the authorized number of shares of common stock from 33,333,333 shares to 125,000,000 shares.
4.To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2020.
5.To conduct any other business properly brought before the Annual Meeting.
|
| 2019-05-22 |
股东大会：
将于2019-06-17召开股东大会
会议内容 ▼▲
- 1.To elect one director to serve a three-year term expiring in 2022;
2.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
3.To transact such other business that is properly presented at the annual meeting and any adjournments or postponements thereof.
|
| 2019-03-14 |
详情>>
拆分方案：
每6.0000合并分成1.0000股
|
| 2018-04-23 |
股东大会：
将于2018-06-05召开股东大会
会议内容 ▼▲
- 1.The election of three Class I directors, William Clark, David McGirr and Claudio Nessi, nominated by our board of directors, each to serve for a three-year term expiring at the 2021 annual meeting of stockholders and until his successor has been duly elected and qualified;
2.The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
3.The transaction of any other business that may properly come before the annual meeting or any adjournment or postponement thereof.
|